Legal Representation
Attorney
Donna J. Bunton
USPTO Deadlines
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 24, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 24, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 10, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 10, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 2, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 30, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 30, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 30, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 18, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 18, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 18, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 18, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 18, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 9, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 18, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 23, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 23, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 3, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 21, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 20, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 15, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 15, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 11, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 6, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 6, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 31, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 19, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 14, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; interferons; parenterally administered interferon for use in treating viral diseases and cancer; intranasal solutions for use as a vaccine adjuvant
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"